Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen R Cole

Showing results (121-130 of 434) with videos related to

Pageof 44
Sort By:
Statistics in Medicine|June 21, 2014
Joint modeling of longitudinal and survival data with missing and left-censored time-varying covariatesQingxia Chen, Ryan C May, Joseph G Ibrahim, et al.
American Journal of Epidemiology|March 30, 2026
The Rogan-Gladen estimator for outcome misclassificationJessie K Edwards, Paul N Zivich, Bonnie E Shook-Sa, et al.
Pharmacoepidemiology and Drug Safety|January 22, 2005
Structural accelerated failure time models for survival analysis in studies with time-varying treatmentsMiguel A Hernán, Stephen R Cole, Joseph Margolick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2013
A systematic review and meta-regression of temporal trends in adult CD4(+) cell count at presentation to HIV care, 1992-2011Catherine R Lesko, Stephen R Cole, Anne Zinski, et al.
Journal of the Royal Statistical Society. Series A, (Statistics in Society)|December 25, 2023
Estimating SARS-CoV-2 seroprevalenceSamuel P Rosin, Bonnie E Shook-Sa, Stephen R Cole, et al.
American Journal of Epidemiology|August 28, 2024
A minimal nontrivial example of higher-order evidenceStephen R Cole, Bonnie E Shook-Sa, Paul N Zivich, et al.
Epidemiology (Cambridge, Mass.)|October 21, 2015
Selection Bias Due to Loss to Follow Up in Cohort StudiesChanelle J Howe, Stephen R Cole, Bryan Lau, et al.
Plos One|December 12, 2018
Sensitivity analyses for effect modifiers not observed in the target population when generalizing treatment effects from a randomized controlled trial: Assumptions, models, effect scales, data scenarios, and implementation detailsTrang Quynh Nguyen, Benjamin Ackerman, Ian Schmid, et al.
Pharmacoepidemiology and Drug Safety|February 26, 2011
The role of the c-statistic in variable selection for propensity score modelsDaniel Westreich, Stephen R Cole, Michele Jonsson Funk, et al.
American Journal of Epidemiology|May 24, 2017
Transportability of Trial Results Using Inverse Odds of Sampling WeightsDaniel Westreich, Jessie K Edwards, Catherine R Lesko, et al.
Pageof 44

Showing results (121-130 of 434) with videos related to

Sort By:
Pageof 44
Statistics in Medicine|June 21, 2014
Joint modeling of longitudinal and survival data with missing and left-censored time-varying covariatesQingxia Chen, Ryan C May, Joseph G Ibrahim, et al.
American Journal of Epidemiology|March 30, 2026
The Rogan-Gladen estimator for outcome misclassificationJessie K Edwards, Paul N Zivich, Bonnie E Shook-Sa, et al.
Pharmacoepidemiology and Drug Safety|January 22, 2005
Structural accelerated failure time models for survival analysis in studies with time-varying treatmentsMiguel A Hernán, Stephen R Cole, Joseph Margolick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2013
A systematic review and meta-regression of temporal trends in adult CD4(+) cell count at presentation to HIV care, 1992-2011Catherine R Lesko, Stephen R Cole, Anne Zinski, et al.
Journal of the Royal Statistical Society. Series A, (Statistics in Society)|December 25, 2023
Estimating SARS-CoV-2 seroprevalenceSamuel P Rosin, Bonnie E Shook-Sa, Stephen R Cole, et al.
American Journal of Epidemiology|August 28, 2024
A minimal nontrivial example of higher-order evidenceStephen R Cole, Bonnie E Shook-Sa, Paul N Zivich, et al.
Epidemiology (Cambridge, Mass.)|October 21, 2015
Selection Bias Due to Loss to Follow Up in Cohort StudiesChanelle J Howe, Stephen R Cole, Bryan Lau, et al.
Plos One|December 12, 2018
Sensitivity analyses for effect modifiers not observed in the target population when generalizing treatment effects from a randomized controlled trial: Assumptions, models, effect scales, data scenarios, and implementation detailsTrang Quynh Nguyen, Benjamin Ackerman, Ian Schmid, et al.
Pharmacoepidemiology and Drug Safety|February 26, 2011
The role of the c-statistic in variable selection for propensity score modelsDaniel Westreich, Stephen R Cole, Michele Jonsson Funk, et al.
American Journal of Epidemiology|May 24, 2017
Transportability of Trial Results Using Inverse Odds of Sampling WeightsDaniel Westreich, Jessie K Edwards, Catherine R Lesko, et al.
Pageof 44